8194 — Life Balance Sheet
0.000.00%
- ¥211bn
- ¥210bn
- ¥850bn
- 80
- 80
- 92
- 98
Annual balance sheet for Life, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 15,343 | 9,809 | 9,727 | 8,606 | 8,366 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 32,907 | 36,677 | 38,873 | 41,632 | 53,004 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 74,668 | 74,480 | 80,490 | 82,849 | 96,348 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 147,452 | 150,490 | 155,880 | 156,315 | 161,351 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 268,307 | 270,229 | 280,810 | 287,146 | 306,027 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 130,466 | 132,478 | 128,236 | 118,219 | 129,927 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 170,747 | 159,930 | 158,808 | 150,291 | 167,592 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 97,560 | 110,299 | 122,002 | 136,855 | 138,435 |
| Total Liabilities & Shareholders' Equity | 268,307 | 270,229 | 280,810 | 287,146 | 306,027 |
| Total Common Shares Outstanding |